01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $2.01B
2 older moves run past ±150% (largest +366.1%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is BridgeBio Pharma's current long-term debt?
BridgeBio Pharma (BBIO) annual long-term debt for 2025 was $2.01B, a 358.99% increase from 2024. BridgeBio Pharma long-term debt for the quarter ending September 30, 2026 was $2.63B.
What was BridgeBio Pharma's long-term debt in 2024?
BridgeBio Pharma annual long-term debt for 2024 was $437.3M, a 2.04% decline from 2023.
What was BridgeBio Pharma's long-term debt in 2023?
BridgeBio Pharma annual long-term debt for 2023 was $446.4M, a 3.59% increase from 2022.
What is BridgeBio Pharma's 5-year long-term debt CAGR?
BridgeBio Pharma long-term debt grew at a compound annual growth rate (CAGR) of 85.08% from FY2020 to FY2025, going from $92.4M to $2.01B over 5 years.
- Company
- BridgeBio Pharma
- Ticker
- BBIO
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations